StonvexLoading…
StonvexStonvexStonvexCore line items from MSS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-01-31 | Q4 2025 2025-10-31 | Q1 2025 2025-01-31 | Q4 2024 2024-10-31 |
|---|---|---|---|---|
Revenue | $84.33M | $54.79M | $89.85M | $57.53M |
Operating Income | $-3.99M | $-1.17M | $4.18M | $3.00M |
Net Income | $-11.72M | $-6.51M | $1.46M | $444.90K |
EPS (Diluted) | $-0.53 | $-0.32 | $0.08 | $0.02 |
Total Assets | $72.09M | $75.44M | $82.74M | $82.74M |
Total Liabilities | $64.53M | $63.97M | $70.73M | $71.72M |
Cash & Equivalents | $1.52M | $1.37M | $445.36K | $355.67K |
Free Cash Flow OCF − CapEx | $897.18K | $-637.48K | $6.23M | $4.57M |
Shares Outstanding | 26.43M | 25.00M | 17.45M | 19.69M |